1. Home
  2. ANIP vs HTO Comparison

ANIP vs HTO Comparison

Compare ANIP & HTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • HTO
  • Stock Information
  • Founded
  • ANIP 2001
  • HTO 1985
  • Country
  • ANIP United States
  • HTO United States
  • Employees
  • ANIP N/A
  • HTO N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • HTO Water Supply
  • Sector
  • ANIP Health Care
  • HTO Utilities
  • Exchange
  • ANIP Nasdaq
  • HTO Nasdaq
  • Market Cap
  • ANIP 2.0B
  • HTO 1.7B
  • IPO Year
  • ANIP N/A
  • HTO N/A
  • Fundamental
  • Price
  • ANIP $91.65
  • HTO $48.01
  • Analyst Decision
  • ANIP Strong Buy
  • HTO Hold
  • Analyst Count
  • ANIP 8
  • HTO 1
  • Target Price
  • ANIP $93.63
  • HTO $58.00
  • AVG Volume (30 Days)
  • ANIP 318.4K
  • HTO 245.4K
  • Earning Date
  • ANIP 11-07-2025
  • HTO 10-27-2025
  • Dividend Yield
  • ANIP N/A
  • HTO 3.50%
  • EPS Growth
  • ANIP N/A
  • HTO 12.08
  • EPS
  • ANIP N/A
  • HTO 3.05
  • Revenue
  • ANIP $747,399,000.00
  • HTO $788,737,000.00
  • Revenue This Year
  • ANIP $39.36
  • HTO $8.17
  • Revenue Next Year
  • ANIP $9.45
  • HTO $6.15
  • P/E Ratio
  • ANIP N/A
  • HTO $15.76
  • Revenue Growth
  • ANIP 38.68
  • HTO 12.40
  • 52 Week Low
  • ANIP $52.50
  • HTO $44.91
  • 52 Week High
  • ANIP $99.50
  • HTO $60.56
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 46.26
  • HTO 43.47
  • Support Level
  • ANIP $88.19
  • HTO $46.46
  • Resistance Level
  • ANIP $92.52
  • HTO $47.85
  • Average True Range (ATR)
  • ANIP 2.40
  • HTO 0.89
  • MACD
  • ANIP -0.93
  • HTO -0.05
  • Stochastic Oscillator
  • ANIP 26.50
  • HTO 40.85

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About HTO H2O America Common Stock

H2O America is a national investor-owned network of local water and wastewater utilities united by one purpose: delivering clean, high-quality water to the communities it calls home. Across approximately 407,000 water and wastewater service connections, the company invests in critical infrastructure to strengthen the water supply for generations to come.

Share on Social Networks: